Substance Use Disorder Research and Scholarly Resources

Key Takeaways

• NIDA (National Institute on Drug Abuse) is the largest funder of addiction research in the world, with an annual budget exceeding $1.6 billion as of fiscal year 2024 (NIDA, 2024).
• SAMHSA’s National Survey on Drug Use and Health (NSDUH) is the primary source for US substance use prevalence data, surveying approximately 70,000 individuals annually (SAMHSA, 2024).
• PubMed Central provides free access to over 8 million full-text biomedical research articles, including a substantial body of addiction research (NIH/NLM, 2024).
• The Rutgers Center of Alcohol Studies, founded in 1940, is the oldest alcohol research center in the US and remains a significant contributor to addiction science (Rutgers University, 2024).
• Randomized controlled trials (RCTs) remain the gold standard for evaluating treatment effectiveness, but observational studies and systematic reviews also provide valuable evidence (Cochrane Collaboration, 2023).

Statistics updated quarterly. Last reviewed March 28, 2026.

---

Understanding the research landscape of substance use disorders is essential for anyone evaluating treatment options, assessing the evidence behind specific interventions, or interpreting the statistics that appear throughout public health discussions. The field of addiction science encompasses neurobiology, pharmacology, epidemiology, behavioral health, and public policy. This page identifies the major research organizations, journals, data sources, and NJ-specific institutions that produce and disseminate substance use disorder research, and provides guidance on evaluating research quality.

Major Addiction Research Organizations

NIDA (National Institute on Drug Abuse)

The National Institute on Drug Abuse, part of the National Institutes of Health (NIH), is the world’s largest funder of addiction research. NIDA’s annual budget exceeded $1.6 billion in fiscal year 2024 (NIDA budget report, 2024).

NIDA’s research portfolio includes:

• Basic neuroscience of addiction: how drugs affect the brain’s reward, stress, and executive function circuits.
• Epidemiological surveillance: NIDA supports the Monitoring the Future survey (tracking adolescent substance use), co-funds components of the NSDUH, and maintains research networks tracking drug use trends.
• Treatment development: NIDA’s Clinical Trials Network (CTN) conducts multi-site randomized controlled trials of addiction treatments. CTN studies have produced foundational evidence for buprenorphine, extended-release naltrexone, and behavioral interventions (NIDA CTN, 2024).
• Policy research: NIDA funds research on the effectiveness of drug courts, medication-assisted treatment policies, and harm reduction approaches.

NIDA’s website (drugabuse.gov, now nida.nih.gov) provides research summaries, treatment guides, and data tools accessible to both researchers and the general public. Their Principles of Drug Addiction Treatment publication, last updated in 2018, remains the most widely cited summary of evidence-based treatment principles.

NIAAA and SAMHSA Research Divisions

NIAAA (National Institute on Alcohol Abuse and Alcoholism): NIAAA is the NIH institute dedicated specifically to alcohol research. With a budget of approximately $575 million in fiscal year 2024, NIAAA funds research on alcohol’s effects on the brain and body, epidemiology of alcohol use disorders, and treatment development (NIAAA, 2024). NIAAA produces the Alcohol Treatment Navigator and maintains the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a major longitudinal dataset.

SAMHSA (Substance Abuse and Mental Health Services Administration): While SAMHSA is primarily a service and policy agency rather than a research institution, its data collection programs produce critical epidemiological data:

• NSDUH: The National Survey on Drug Use and Health surveys approximately 70,000 individuals annually, producing national and sub-state estimates of substance use, mental health, and treatment utilization (SAMHSA, 2024).
• TEDS: The Treatment Episode Data Set compiles admissions data from publicly funded treatment facilities.
• DAWN: The Drug Abuse Warning Network tracked drug-related emergency department visits (discontinued in 2011, partially replaced by newer surveillance systems).
• National Registry of Evidence-based Programs and Practices (NREPP): Though discontinued in its original form, SAMHSA maintains information on evidence-based treatment practices.

Key Journals in Addiction Research

Peer-Reviewed Addiction Journals

The following journals represent the primary outlets for substance use disorder research, listed with their impact factors and areas of focus:

• Addiction (Wiley, impact factor approximately 6.3): One of the oldest and most prestigious addiction journals, covering all substance use and behavioral addictions. Published by the Society for the Study of Addiction (2024).
• Drug and Alcohol Dependence (Elsevier, impact factor approximately 4.2): Broad coverage of pharmacology, epidemiology, neuroscience, and treatment research across all substances (2024).
• Journal of Substance Abuse Treatment (Elsevier, impact factor approximately 3.7): Focused specifically on treatment research, including clinical trials, policy evaluation, and service delivery (2024).
• Alcoholism: Clinical and Experimental Research (Wiley, impact factor approximately 3.8): The journal of the Research Society on Alcohol, covering both clinical and basic science research on alcohol (2024).
• The American Journal of Drug and Alcohol Abuse (Taylor & Francis, impact factor approximately 3.2): Clinical research focused on treatment and epidemiology.
• Journal of Addiction Medicine (Wolters Kluwer): The official journal of the American Society of Addiction Medicine (ASAM), with a clinical practice focus.

General medical journals also regularly publish high-impact addiction research, including JAMA, The New England Journal of Medicine, The Lancet, The BMJ, and JAMA Psychiatry.

Where to Find Open-Access Research

Accessing addiction research does not require journal subscriptions:

• PubMed Central (PMC): All NIH-funded research must be deposited in PMC within 12 months of publication. As of 2024, PMC contains over 8 million full-text articles, including a substantial proportion of addiction research (NIH/NLM, 2024). Accessible at ncbi.nlm.nih.gov/pmc.
• PubMed: The broader PubMed database indexes over 36 million citations. While not all articles are full-text accessible, PubMed provides abstracts for virtually all biomedical literature. Accessible at pubmed.ncbi.nlm.nih.gov.
• Cochrane Library: Cochrane systematic reviews provide rigorous meta-analyses of treatment evidence. Many Cochrane reviews on addiction treatment are freely accessible (cochranelibrary.com).
• Google Scholar: A broad search engine for academic literature, useful for finding working papers, dissertations, and pre-prints alongside published journal articles (scholar.google.com).
• NIDA publications: NIDA publishes research summaries, DrugFacts sheets, and research monographs that synthesize technical findings into accessible language (nida.nih.gov).

Understanding Addiction Epidemiology Data

NSDUH and TEDS

The two primary epidemiological datasets in US addiction research are:

NSDUH (National Survey on Drug Use and Health):

• What it measures: Self-reported substance use, substance use disorders, mental health conditions, and treatment utilization among the US civilian, non-institutionalized population aged 12 and older.
• Methodology: In-person household interviews with approximately 70,000 respondents annually. Audio computer-assisted self-interview (ACASI) technology is used for sensitive questions to improve honest reporting.
• Strengths: Large sample size, annual data, sub-state estimates available.
• Limitations: Excludes homeless individuals, active military, and incarcerated populations. Self-report introduces underreporting bias, particularly for stigmatized substances and illegal behavior.

TEDS (Treatment Episode Data Set):

• What it measures: Admissions to substance use treatment facilities that receive public funding.
• Strengths: Captures demographic and substance-specific information at the point of treatment entry.
• Limitations: Does not capture private treatment admissions or treatment outcomes. Does not distinguish between unique individuals and repeat admissions.

CDC WONDER and Mortality Data

CDC WONDER (Wide-ranging ONline Data for Epidemiologic Research):

• What it measures: Mortality data from death certificates, including drug overdose deaths classified by ICD-10 codes.
• Strengths: Covers all US deaths (not a sample), provides county-level data, allows queries by age, race, gender, and substance type.
• Limitations: Depends on accurate death certificate coding, which varies by jurisdiction. Some counties list “unspecified” drugs rather than specific substances, and specific substance identification improved significantly after 2016 when coding protocols were updated.
• Provisional vs. final data: The CDC releases provisional mortality data with a lag of approximately 6 months. Final data is available 11-14 months after the end of the data year. Provisional data may be revised when final data is released.

How to Evaluate Addiction Research Quality

Study Design Hierarchy

Not all research carries equal weight. The standard hierarchy of evidence, from strongest to weakest:

1. Systematic reviews and meta-analyses: Synthesize results from multiple studies. Cochrane reviews are considered the gold standard for systematic reviews.
2. Randomized controlled trials (RCTs): Randomly assign participants to treatment and control conditions, minimizing bias. RCTs are the strongest individual study design for evaluating treatment effectiveness.
3. Cohort studies: Follow groups of people over time, comparing those who receive treatment to those who do not. Useful for long-term outcome data but subject to selection bias.
4. Cross-sectional studies: Provide a snapshot at one point in time. Useful for prevalence estimates but cannot establish causation.
5. Case series and case reports: Describe outcomes for small numbers of patients. Useful for generating hypotheses but not for drawing generalizable conclusions.
6. Expert opinion and clinical guidelines: Informed by the evidence base but subject to individual judgment and institutional bias.

Red Flags in Addiction Studies

When evaluating addiction research, particularly claims from treatment facilities or advocacy organizations, watch for:

• No control group: A study that reports outcomes for treated patients without comparing to a similar untreated group cannot distinguish treatment effects from natural recovery.
• Small sample sizes: Studies with fewer than 50-100 participants generally lack statistical power to detect meaningful differences.
• Short follow-up: Outcomes measured at less than six months post-treatment have limited relevance for understanding long-term recovery.
• Undisclosed funding sources: Research funded by pharmaceutical companies or treatment facility chains may have conflicts of interest. The Declaration of Helsinki and ICMJE guidelines require funding disclosure, but not all publications comply fully.
• Cherry-picked outcomes: Reporting only the most favorable outcome measure while ignoring others.
• Survivorship bias: Following up only with patients who are reachable, which systematically excludes those who have relapsed, become homeless, or died.

NJ-Based Addiction Research

Rutgers Center of Alcohol Studies

The Rutgers Center of Alcohol Studies (CAS), founded in 1940, is the oldest alcohol research center in the United States. Initially established at Yale University and relocated to Rutgers in 1962, CAS has been a foundational institution in addiction science (Rutgers University, 2024).

CAS research areas include:

• Neuroscience of alcohol’s effects on the developing brain.
• Epidemiology of alcohol use disorders in diverse populations.
• Development and testing of behavioral interventions for alcohol use disorder.
• Training the next generation of addiction researchers through its doctoral and postdoctoral programs.

CAS maintains the Alcohol Research Documentation Collection, one of the largest libraries of alcohol research literature in the world.

Other NJ Research Institutions

• Rutgers University Behavioral Health Care: Operates clinical programs and conducts health services research on substance use treatment delivery and outcomes in NJ (Rutgers UBHC, 2024).
• Rowan University School of Osteopathic Medicine: Conducts research on opioid prescribing patterns, MAT outcomes, and addiction medicine education in southern NJ (Rowan SOM, 2024).
• New Jersey Health Initiatives (NJHI): A Robert Wood Johnson Foundation-funded program that supports community-based research on substance use prevention and health equity in NJ (RWJF, 2024).
• The Center for Health, Identity, Behavior and Prevention Studies (CHIBPS) at Rutgers: Conducts research on substance use in marginalized populations, including LGBTQ+ individuals and communities of color (Rutgers CHIBPS, 2024).

---

This page is part of the Addiction Statistics, Research, and Recovery Data guide on NJ Addiction Centers.

Related resources:

• Substance Use Disorder Life Expectancy and Health Outcomes
• Rehab Success Rates: What the Data Actually Shows
• How Addiction Affects the Brain